Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Physostigmine improves ECT-induced memory disturbances.

Y Levin, A Elizur, A D Korczyn

    Neurology
    |May 1, 1987
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Pseudo-anticipation in Creutzfeldt-Jakob disease is due to a rhomboid-shaped artifact.

    European journal of neurology·2019
    Same author

    Clinical and radiological determinants of transient symptoms associated with infarction (TSI).

    Journal of the neurological sciences·2018
    Same author

    High hair cortisol concentrations predict worse cognitive outcome after stroke: Results from the TABASCO prospective cohort study.

    Psychoneuroendocrinology·2017
    Same author

    Gait instability in valproate-treated patients: Call to measure ammonia levels.

    Acta neurologica Scandinavica·2017
    Same author

    Quality-of-life perception by Parkinson's disease patients and caregivers.

    Acta neurologica Scandinavica·2017
    Same author

    The effect of schooling on reported age of onset of cognitive decline: A collaborative study.

    Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia·2016
    Same journal

    Teaching Video NeuroImage: Tardive Blepharoclonus.

    Neurology·2026
    Same journal

    Teaching NeuroImage: Latent Axonal Degeneration in Patient With Anterior Circulation Stroke.

    Neurology·2026
    Same journal

    Incidental DWI-Positive Lesions in 2 Cohorts of CAA and CADASIL: Prevalence, Distribution, and Associations With Clinical Variables.

    Neurology·2026
    Same journal

    Alpha-Synuclein Seed Amplification Assay in CSF, Skin, and Submandibular Gland From Incidental Lewy Body Disease and Parkinson Disease.

    Neurology·2026
    Same journal

    Digital Semiology.

    Neurology·2026
    Same journal

    Early Cerebral Edema Subtypes and Functional Outcome in Patients With Cerebral Venous Thrombosis: Insights From the CLOT-VENUS Registry.

    Neurology·2026
    See all related articles

    Physostigmine reversed memory loss caused by electroconvulsive therapy (ECT). However, it did not affect immediate recall, which was unaffected by ECT.

    Area of Science:

    • Neuroscience
    • Psychiatry
    • Pharmacology

    Background:

    • Electroconvulsive therapy (ECT) is an effective treatment for severe psychiatric disorders.
    • ECT is associated with transient cognitive side effects, including confusion and amnesia.
    • Memory disturbances following ECT can impact patient recovery and treatment adherence.

    Purpose of the Study:

    • To investigate the efficacy of physostigmine in mitigating ECT-induced memory impairments.
    • To determine the effect of physostigmine on different types of memory (short-term vs. long-term, verbal vs. visual) after ECT.

    Main Methods:

    • A double-blind, crossover study design was employed.
    • Participants received either physostigmine or a placebo before ECT.
    • Memory function was assessed using standardized tests for verbal and visual short- and long-term recall.

    Related Experiment Videos

    Main Results:

    • Physostigmine significantly reversed impairments in verbal and visual short- and long-term memory following ECT.
    • Immediate recall, a measure of very short-term memory, was not affected by ECT or physostigmine treatment.
    • The findings suggest a specific effect of physostigmine on consolidation and retrieval processes affected by ECT.

    Conclusions:

    • Physostigmine demonstrates potential as an adjunct treatment to reduce cognitive side effects of ECT.
    • Targeting cholinergic pathways with physostigmine may offer a strategy to improve memory function after ECT.
    • Further research is warranted to explore optimal dosing and long-term effects of physostigmine in ECT patients.